The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1419
June 24, 2013
View Complete Issue         Table of Contents 2019 
Nutritional Supplements for Age-Related Macular Degeneration Revisited
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Nutritional Supplements for Age-Related Macular Degeneration Revisited
June 24, 2013 (Issue: 1419)
The results of the Age-Related Eye Disease Study 2 (AREDS2) have now been published. The primary purpose of the study was to evaluate the efficacy and safety of the carotenoids lutein and zeaxanthin and the omega-3 polyunsaturated fatty acids...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Nutritional Supplements for Age-Related Macular Degeneration Revisited
Article code: 1419b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.